
Sign up to save your podcasts
Or
CVS has itself covered coming and going: It’s not just a retail pharmacy where generics cost twice what they sell for at independent drug stores—it’s also a health insurer, a general retailer and, most lucrative of all, a pharmacy benefits manager. Tie all those together, and you have a healthcare conglomerate whose shares are up more than 50% so far this year.
Good news, right? Well, kinda. Under CEO David Joyner, a 30-year company veteran who took over in October, the company has moved to cut unprofitable business lines, including shutting underperforming stores and getting out of the Obamacare marketplace.
But as Vince Stanzione, an investor who’s taken a deep look at CVS notes, this year’s surge may just be a reversion to the mean. “CVS Health has been a dog of a stock, making no headway over the last decade,” said Stanzione. Over the last 10 years, CVS Health delivered a cumulative total return of -9.06% (-0.95% annualized), significantly underperforming the SPDR S&P 500 ETF, which returned ~223.5% to 247.8% (12.47% to 13.3% annualized).
One big drag on CVS has been its 2018 acquisition of insurer Aetna, for $78 billion including debt. The plan was to build out a network of primary care centers, including Oak Street Health, for seniors on Medicare, and MinuteClinic, in-store healthcare centers at CVS retail locations. But CVS’s market cap today is just over $86 billion, suggesting it overpaid significantly for Aetna.
That’s where Joyner’s restructuring plan comes in. The stock has shot up under his leadership, and while it’s early days, investors clearly see him as a rider to bet on, even if the horse is a little wobbly. Among his recent successes: a deal with Novo Nordisk to make Wegovy the preferred prescription weight-loss drug for its customers. The deal knocks the monthly cost of Wegovy down to $499 for Aetna clients shopping at CVS, a huge drop from the average uninsured price of about $1,350 a month. Some of the stock’s momentum may be coming from expectations of similar deals to come. Particularly with diabetes care.
But the other big cash spinner, CVS’s pharmacy benefit manager business, is not doing so well. Its share of U.S. prescriptions filled dropped to 27% last year from 34% in 2023, largely due to increased competition.
Ultimately, CVS’s success may come from two forces at work right now. The first is the crumbling consumer confidence under Trump. Consumers are pulling back from other spending, and conserving their cash for core expenses, like healthcare, so while the rest of the market is down, consumers are still paying to stay alive. The other may simply be momentum, rather than strong fundamentals in its business model, said Scott Y. Stuart, CEO of the Turnaround Management Association. “The story of optimism in a corporate turnaround is rooted in taking decisive, thoughtful action rather than reactive measures—and that’s exactly what CVS appears to be doing,” Stuart said by email.
Watch Big Business This Week on Cheddar—and YouTube!The Usual SuspectsWhat do you think of Big Business This Week? Tell us how you really feel in this survey!
Car TalkTrump’s crypto scheme is a blueprint for fraud. By pushing digital assets tied to his name, he’s selling access to the highest bidder. It’s a neon sign for foreign influence and a national security threat. My End Crypto Corruption Act would immediately ban this digital bribery.
— Jeff Merkley (@JeffMerkley) May 7, 2025Get Big Business This Week in your inbox every week—and read it before everybody else! Sign up today.
Elon’s WorldAmerica’s favorite investor, Warren Buffett, followed through this week on his decade-old promise to step down as the head of the world’s most successful major investment firm, Berkshire Hathaway. At 94, Buffett has spent 60 years steering Berkshire Hathaway, his investment vehicle and holding company that has owned shares in everything from Coca-Cola and Apple to the Buffalo Evening News, the BNSF railroad, and Geico. Ever since Donald Trump appeared likely to win the presidency in 2024, Buffett moved much of Berkshire’s holdings to cash, and is now sitting on nearly $350 billion.
Berkshire Hathaway’s shares have risen 5,502,284% between the time Buffett took over a failing textile company in 1965 and the end of 2024, according to the company’s most recent annual report. The S&P 500 rose 39,054% during that period, with dividends. Buffett was a value investor, following the principles of Benjamin Graham by basing his investments on the long-term prospects of the companies, and often taking a role in managing them.
“The billionaire always comes across as a gentleman, and in an age of distrust he became someone people could trust,” the New York Times wrote of Buffett. At Berkshire Hathaway’s annual meeting last weekend in Omaha, Buffett announced his departure with some strong words for Trump: “Trade should not be a weapon,” he told a crowd of some 40,000 people. “I do think that the more prosperous the rest of the world becomes, it won’t be at our expense, the more prosperous we’ll become, and the safer we’ll feel, and your children will feel someday.”
CVS has itself covered coming and going: It’s not just a retail pharmacy where generics cost twice what they sell for at independent drug stores—it’s also a health insurer, a general retailer and, most lucrative of all, a pharmacy benefits manager. Tie all those together, and you have a healthcare conglomerate whose shares are up more than 50% so far this year.
Good news, right? Well, kinda. Under CEO David Joyner, a 30-year company veteran who took over in October, the company has moved to cut unprofitable business lines, including shutting underperforming stores and getting out of the Obamacare marketplace.
But as Vince Stanzione, an investor who’s taken a deep look at CVS notes, this year’s surge may just be a reversion to the mean. “CVS Health has been a dog of a stock, making no headway over the last decade,” said Stanzione. Over the last 10 years, CVS Health delivered a cumulative total return of -9.06% (-0.95% annualized), significantly underperforming the SPDR S&P 500 ETF, which returned ~223.5% to 247.8% (12.47% to 13.3% annualized).
One big drag on CVS has been its 2018 acquisition of insurer Aetna, for $78 billion including debt. The plan was to build out a network of primary care centers, including Oak Street Health, for seniors on Medicare, and MinuteClinic, in-store healthcare centers at CVS retail locations. But CVS’s market cap today is just over $86 billion, suggesting it overpaid significantly for Aetna.
That’s where Joyner’s restructuring plan comes in. The stock has shot up under his leadership, and while it’s early days, investors clearly see him as a rider to bet on, even if the horse is a little wobbly. Among his recent successes: a deal with Novo Nordisk to make Wegovy the preferred prescription weight-loss drug for its customers. The deal knocks the monthly cost of Wegovy down to $499 for Aetna clients shopping at CVS, a huge drop from the average uninsured price of about $1,350 a month. Some of the stock’s momentum may be coming from expectations of similar deals to come. Particularly with diabetes care.
But the other big cash spinner, CVS’s pharmacy benefit manager business, is not doing so well. Its share of U.S. prescriptions filled dropped to 27% last year from 34% in 2023, largely due to increased competition.
Ultimately, CVS’s success may come from two forces at work right now. The first is the crumbling consumer confidence under Trump. Consumers are pulling back from other spending, and conserving their cash for core expenses, like healthcare, so while the rest of the market is down, consumers are still paying to stay alive. The other may simply be momentum, rather than strong fundamentals in its business model, said Scott Y. Stuart, CEO of the Turnaround Management Association. “The story of optimism in a corporate turnaround is rooted in taking decisive, thoughtful action rather than reactive measures—and that’s exactly what CVS appears to be doing,” Stuart said by email.
Watch Big Business This Week on Cheddar—and YouTube!The Usual SuspectsWhat do you think of Big Business This Week? Tell us how you really feel in this survey!
Car TalkTrump’s crypto scheme is a blueprint for fraud. By pushing digital assets tied to his name, he’s selling access to the highest bidder. It’s a neon sign for foreign influence and a national security threat. My End Crypto Corruption Act would immediately ban this digital bribery.
— Jeff Merkley (@JeffMerkley) May 7, 2025Get Big Business This Week in your inbox every week—and read it before everybody else! Sign up today.
Elon’s WorldAmerica’s favorite investor, Warren Buffett, followed through this week on his decade-old promise to step down as the head of the world’s most successful major investment firm, Berkshire Hathaway. At 94, Buffett has spent 60 years steering Berkshire Hathaway, his investment vehicle and holding company that has owned shares in everything from Coca-Cola and Apple to the Buffalo Evening News, the BNSF railroad, and Geico. Ever since Donald Trump appeared likely to win the presidency in 2024, Buffett moved much of Berkshire’s holdings to cash, and is now sitting on nearly $350 billion.
Berkshire Hathaway’s shares have risen 5,502,284% between the time Buffett took over a failing textile company in 1965 and the end of 2024, according to the company’s most recent annual report. The S&P 500 rose 39,054% during that period, with dividends. Buffett was a value investor, following the principles of Benjamin Graham by basing his investments on the long-term prospects of the companies, and often taking a role in managing them.
“The billionaire always comes across as a gentleman, and in an age of distrust he became someone people could trust,” the New York Times wrote of Buffett. At Berkshire Hathaway’s annual meeting last weekend in Omaha, Buffett announced his departure with some strong words for Trump: “Trade should not be a weapon,” he told a crowd of some 40,000 people. “I do think that the more prosperous the rest of the world becomes, it won’t be at our expense, the more prosperous we’ll become, and the safer we’ll feel, and your children will feel someday.”
14,160 Listeners
1,205 Listeners
111,266 Listeners
56,061 Listeners
1,362 Listeners
2,114 Listeners
1,872 Listeners
6,312 Listeners
3,622 Listeners
6,442 Listeners
6,233 Listeners
574 Listeners
5,969 Listeners
1,465 Listeners
41,209 Listeners